Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links
PHARMA - SNUPPY, THE FIRST EVER CLONED DOG

Snuppy: The first cloned dog

snuppy image

 

BY OUR PHARMA  CORRESPONDENT

4 August, 2005: The South Korean researchers have successfully created the first-ever dog clone, reports Nature.

Deemed as the most difficult animal to be cloned, a male Afghan hound was born by cesarean section on April 24 to a yellow Labrador surrogate mother and turned 100 days old on (August 2), say the researchers' Seoul National University.

Scientists named him Snuppy (short for Seoul National University puppy).

The team worked for nearly three years, seven days a week, 365 days a year and used 1,095 eggs from 122 dogs before finally succeeding with the birth. The pregnancy lasted a normal 60 days and the newborn pup weighed 1 pound 3.4 ounces

snuppy photo

Dogs have complicated reproductive biology, far more so than humans, that the methods that allowed cloning of sheep, mice, cows, goats, pigs, rabbits, cats, a mule, a horse and three rats, and creation of cloned human embryos for stem cells, simply do not work with them, scientists say.

A second cloned dog lived just 22 days before succumbing to aspiration pneumonia. A postmortem analysis showed no signs of "any congenital defect due to cloning," said Woo Suk Hwang, the leader of the Korean team. A third pregnancy resulted in a miscarriage.

Until now, somatic cell cloning in dogs has been hampered by limited success in maturing canine eggs in the lab, said Hwang. Such maturation is necessary because unlike those of other domestic animals, canine eggs aren't mature at ovulation. They're ovulated at prophase of the first meiotic division and undergo maturation in the distal part of the oviduct for at least 48 to 72 hours. The dog's opaque ova also make manipulation difficult.

So the researchers had to pinpoint when to pluck a mature egg from the oviduct, and needed surgery to retrieve it, instead of the kind of needle suctioning used in other animals.

The next step in cloning of any other animal is to replace the egg's genes with those of an adult and let the cloned embryo grow in the lab for several days.

But no one has been able to grow dog embryos in the lab. So the South Koreans quickly started the cloning. They removed the genetic material from the eggs and replaced it with skin cells from the ears of Afghan hounds. When the altered eggs were starting to develop into embryos, the researchers anesthetized a female dog, slipped the eggs into the animal's oviduct, and hoped the eggs would grow into early embryos, drift into the uterus, and survive. They found they had less than four hours after starting the process to get the eggs into the female dogs.

Ordinarily, researchers give hormones to female animals that are to serve as surrogate mothers, preparing them to become pregnant with a cloned embryo. Not so with dogs.

The team chose an Afghan hound because the dog was known to have a "gentle and docile pedigree," Hwang said. They also had access to a good collection of photos of the dog, which had unique fur color and appearance, when it was a puppy, he said, making it easier to distinguish whether the clone was identical. Microsatellite analysis of genomic DNA from the donor, the cloned dogs, and the surrogates confirmed that the clones were genetically identical to the donor.

However, experts believe that only few would be able to afford cloned dogs in the near future as it the entire procedure is estimated to more than $1 million.

BY OUR PHARMA  CORRESPONDENT

Pharma News Headlines

Cancer News

Cardiac News

US FDA News

Pharma industry news

LATEST UPDATES

Heart disease deaths more among New Yorkers

Pfizer to offer drugs risk/benefit summary to consumers 

Merck lied to public on Vioxx: lawyer tells jurors

Novartis acquires rights of kidney dialysis drug from SeBo

J&J's Concerta approved treatment of ADHD in teenagers in Canada

US FDA stalls Roche’ Accutane use in pregnancy

Novo Nordisk, Eli Lilly remove insulin products from Australia

British drug supply chain safety questioned after another fake Lipitor find

Wyeth starts support programme for Effexor patients

P&G’s Actonel with Calcium approved for osteoporosis

Pozen gets patent on pain management product

Genmab studies new drug for rheumatoid arthritis

Painkillers may increase blood pressure: study

Nektar buys out Aerogen for $32 m

Predix records positive data on anxiety drug

Insmed files against Increlex approval

Hepatitis A vaccine for kids approved in US

Psoriasis drug data positive: Cytochroma

Novo Nordisk’s 24-hour acting insulin Levemir gets US FDA okay

US FDA approves Teva's generic for osteoporosis 

Pfizer files NDA for Sutent in US

BioVeris licenses Baxter's vaccine portfolio

TheraQuest receives 2nd Orphan Drug status for neuralgia drug

Real-time glucose monitoring device approved in US

Halozyme gets FDA nod for bladder cancer therapy

Migenix to commence phase 2b studies in hep C therapy

Barr gets US FDA okay for clonazepam tabs

Anorexia drug study results positive: Par

GlaxoSmithKline begins phase III trials of new HIV drug

Ranbaxy's 7 anti retrovirals included in WHO list

FDA tightens restrictions on acne drug

Voglibose tabs launched in Japan

Remicade researcher gifts $ 105m to NYU

Par loses ondansetron case to GSK

Mistral starts clinical studies for generic

Carl Icahn sells Mylan shares

Florida sues Mylan, Teva and Watson

Dey and Connecticut settle pricing dispute

Germany set to stop rabies crossing borders

Office to review DTC drug advertisements in US

British docs to be trained in communication, safety

FDA okays acrylic lens for cataract patients 

Corautus to go ahead with angina drug studies 

Americans turn the low-fat way

Chemicals in plastics pose danger

US committee probes doctors’ complicity with Wall Street analysts

Meda buys out rival Viatris

US FDA nod for new levofloxacin regimen to treat acute bacterial sinusitis

Pozen files for new migraine treatment

New therapy for pancreatic cancer under review

New device inducing blood flow to heart granted US patent

NIH announces grants for faster, cheaper DNA sequencing

DOV starts phase III trial of pain drug in US

Alcohol linked cancers: Acetaldehyde in spot light

Hypertension `just above normal’ too risky

Gene causes infertility drugs go awry: study

China’s pig flu outbreak

Cardiac Science-Defibtech lawsuit settled

Peregrine starts Phase-1 anti-viral trial of Tarvacin

Dr. Reddy's launches immune booster for children

Lupin in pact with Kyowa of Japan

Bird flu vaccine may work in humans: US researchers

 

 

Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links

Latest updates    Contact Us - Feedback    About Us